Literature DB >> 11718406

Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation.

M Schillinger1, M Haumer, G Schlerka, W Mlekusch, M Exner, R Ahmadi, E Minar.   

Abstract

PURPOSE: To determine the value of baseline C-reactive protein (CPR), fibrinogen, and white blood cell (WBC) counts in predicting 1-year patency after percutaneous transluminal angioplasty (PTA) in the femoropopliteal segment.
METHODS: In a retrospective cohort study, 168 consecutive patients (103 men; median age 70 years, interquartile range 61-77) who underwent successful PTA of the femoral and/or popliteal arteries were analyzed. Twelve-month patency was evaluated using oscillography, ankle brachial index, duplex sonography, and angiography. The predictive value of inflammatory markers was assessed in a multivariate model controlling for cardiovascular risk factors, technical success, and hemodynamic factors.
RESULTS: Transient WBC elevation was found 6 hours after PTA, but this returned to baseline after 24 hours. Fibrinogen was elevated at 24 hours. Duplex scanning disclosed restenosis in 66 (39%) patients within the first 12 months after PTA. Only residual postdilation stenosis (> or = 30%) in the target segment (odds ratio 3.6, p=0.001) and baseline CRP levels (odds ratio 4.2, p=0.02) were independent predictors of outcome; neither WBC counts nor fibrinogen levels at any time point was associated with restenosis.
CONCLUSIONS: Primary technical success and postinterventional hemodynamic flow at the dilated segment seem to be more important for intermediate-term patency than atherogenic risk factors. The predictive value of preprocedural serum CRP levels on restenosis should be further investigated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11718406     DOI: 10.1177/152660280100800509

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  9 in total

1.  Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons.

Authors:  Emily A Turner; Marzieh K Atigh; Megan M Erwin; Uwe Christians; Saami K Yazdani
Journal:  Cardiovasc Eng Technol       Date:  2018-03-01       Impact factor: 2.495

2.  C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.

Authors:  Patrick A Stone; Haley Schlarb; John E Campbell; David Williams; Stephanie N Thompson; Molly John; James R Campbell; Ali F AbuRahma
Journal:  J Vasc Surg       Date:  2014-04-29       Impact factor: 4.268

3.  Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.

Authors:  Christopher D Owens; Paul M Ridker; Michael Belkin; Allen D Hamdan; Frank Pomposelli; Frank Logerfo; Mark A Creager; Michael S Conte
Journal:  J Vasc Surg       Date:  2006-11-21       Impact factor: 4.268

4.  Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization.

Authors:  Christopher D Owens; Warren J Gasper; Joy P Walker; Hugh F Alley; Michael S Conte; S Marlene Grenon
Journal:  J Vasc Surg       Date:  2014-01-11       Impact factor: 4.268

5.  Physical activity during daily life and circulating biomarker levels in patients with peripheral arterial disease.

Authors:  Lynette L Craft; Jack M Guralnik; Luigi Ferrucci; Kiang Liu; Lu Tian; Michael H Criqui; Jin Tan; Mary M McDermott
Journal:  Am J Cardiol       Date:  2008-09-05       Impact factor: 2.778

Review 6.  Restenosis after percutaneous angioplasty: the role of vascular inflammation.

Authors:  Martin Schillinger; Erich Minar
Journal:  Vasc Health Risk Manag       Date:  2005

7.  Primary stenting for femoropopliteal peripheral arterial disease: analysis up to 24 months.

Authors:  Martin Andreas Geiger; Ana Terezinha Guillaumon
Journal:  J Vasc Bras       Date:  2019-01-30

Review 8.  The Impact of Antithrombotic Regimens on Clinical Outcomes After Endovascular Intervention and Bypass Surgery for Infrapopliteal Artery Disease.

Authors:  Amol Gupta; Michael S Lee; Kush Gupta; Vinod Kumar; Sarath Reddy
Journal:  Cardiol Res       Date:  2019-10-04

9.  Interleukin-1/toll-like receptor-induced nuclear factor kappa B signaling participates in intima hyperplasia after carotid artery balloon injury in goto-kakizaki rats: a potential target therapy pathway.

Authors:  Xiaotian Zhang; Yi Wang; Wenjing Hu; Dongye Li; Zhongmin Zhou; Defeng Pan; Wanling Wu; Tongda Xu
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.